Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction

Yee H Looi1, David J Grieve, Anjana Siva

  • 1Department of Cardiology, King's College London School of Medicine, James Black Centre, 125 Coldharbour Ln, London SE5 9NU, United Kingdom.

Insights

Mice lacking Nox2, an enzyme linked to oxidative stress, showed reduced cardiac remodeling and improved heart function after myocardial infarction (MI). This suggests Nox2 contributes to post-MI heart damage.

Area of Science:

  • Cardiovascular Research
  • Oxidative Stress Biology
  • Molecular Cardiology

Background:

  • Oxidative stress is implicated in cardiac remodeling post-myocardial infarction (MI).
  • The specific sources of oxidative stress contributing to adverse cardiac remodeling remain largely undefined.
  • Nox2-containing NADPH oxidase is a potential key mediator of oxidative stress in the heart.

Purpose of the Study:

  • To investigate the role of Nox2-containing NADPH oxidase in cardiac remodeling following MI.
  • To determine if inhibiting Nox2 can mitigate adverse cardiac structural and functional changes post-MI.

Main Methods:

  • Adult Nox2 knockout (Nox2(-/-)) and wild-type (WT) mice underwent coronary artery ligation to induce MI.
  • Cardiac structure and function were assessed 4 weeks post-MI using echocardiography and invasive hemodynamic measurements.
  • Histological analyses evaluated infarct size, cardiomyocyte hypertrophy, apoptosis, interstitial fibrosis, and molecular markers of remodeling.

Main Results:

  • Infarct size was comparable between Nox2(-/-) and WT mice.
  • Nox2(-/-) mice exhibited significantly reduced left ventricular (LV) dilatation and preserved LV systolic and diastolic function compared to WT mice post-MI.
  • Nox2 deficiency led to decreased cardiomyocyte hypertrophy, apoptosis, interstitial fibrosis, and reduced expression of fibrotic and matrix metalloproteinase markers.

Conclusions:

  • The Nox2-containing NADPH oxidase plays a significant role in adverse cardiac remodeling and contractile dysfunction after myocardial infarction.
  • Targeting Nox2 may represent a therapeutic strategy to prevent or treat heart failure post-MI.